BF-B
Brown-Forman Corporation
BF-B has lower modeled downside risk, despite its lower overall score.
CELH
Celsius Holdings, Inc.
CELH has the edge over BF-B overall, supported by stronger fundamentals and stronger modeled upside.
BF-B Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
BF-B's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BF-B PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $25.70 | -14% |
| Forward | 18x | $30.04 | — |
| Current | 19x | $30.04 | — |
| Fair | 36x | $55.07 | +83% |
| Expensive | 40x | $62.69 | +109% |
Historical ranges are pointers, not guarantees.
BF-B's PE is in its cheap range at 19x. If earnings grow as analysts expect, today's price would be 18x next year's earnings.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over BF-B in the historical PE scenario, which offers more potential upside but is not a forecast.
BF-B Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect BF-B's earnings to grow and its profitability to improve, with its revenue holding steady.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over BF-B on the outlook, with more favorable revenue expectations.
BF-B Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.70 | +9.7% |
| Q3 2026 | $1.55 | -13% |
| Q2 2026 | $1.53 | -17% |
| Q1 2026 | $1.72 | -18% |
| Q4 2025 | $1.71 | -19% |
| Q3 2025 | $1.79 | -14% |
| Q2 2025 | $1.84 | -14% |
| Q1 2025 | $2.09 | +4% |
| Q4 2024 | $2.12 | +31% |
BF-B has the edge over CELH on earnings, with stronger typical year-over-year growth.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
BF-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $911M | -1.4% |
| Q2 2026 | $912M | +2% |
| Q1 2026 | $1.1B | +2% |
| Q4 2025 | $1B | -5.4% |
| Q3 2025 | $924M | -2.8% |
| Q2 2025 | $894M | -7.3% |
| Q1 2025 | $1B | -3.2% |
| Q4 2024 | $1.1B | -1.1% |
BF-B's revenue fell from its 2023 peak and has held roughly level since: $911M last quarter, down 1.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | -0.5 points |
| Q2 2026 | 11% | -12 points |
| Q1 2026 | 32% | +5.2 points |
| Q4 2025 | 29% | -1.7 points |
| Q3 2025 | 28% | -1.4 points |
| Q2 2025 | 23% | -16 points |
| Q1 2025 | 27% | -7.8 points |
| Q4 2024 | 31% | +0.5 points |
BF-B has the edge over CELH on profitability, with a higher operating margin.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over BF-B on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
BF-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $161M | +25% |
| Q2 2026 | $265M | +160% |
| Q1 2026 | $392M | +44% |
| Q4 2025 | $107M | +32% |
| Q3 2025 | $129M | +$153M |
| Q2 2025 | $102M | -50% |
| Q1 2025 | $272M | +39% |
| Q4 2024 | $81M | +179% |
BF-B has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BF-B Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -7.2M shares |
| 1 year | -2.8% | -13.4M shares |
| 3 years | -4.3% | -20.9M shares |
| 5 years | -4.4% | -21.2M shares |
| Available history | -4.4% | -21M shares |
BF-B has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $301M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q2 2024 | — |
| Q1 2024 | $358M |
| Q2 2021 | — |
| Q1 2021 | — |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BF-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.9x | Healthy |
BF-B's net debt is about 2.0 years of its operating earnings (EBITDA), about the same as a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over BF-B on leverage, with a lower net debt burden relative to earnings.
BF-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.1 | Neutral |
| Stochastic | 74.8 | Neutral |
BF-B's weekly RSI is 60 (neutral) and its Stochastic is 75 (neutral).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BF-B PE vs Consumer Defensive Sector
| Metric | BF-B | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 19x | 0.9% below |
| PE % | 27 | 18 | 9 pts above |
BF-B has the edge over CELH on valuation relative to its sector.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BF-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.3 | 6.2% above |
| 20 week MA | $27.5 | 9.1% above |
| 50 week MA | $27.4 | 9.6% above |
| 100 week MA | $29.3 | 2.5% above |
| 200 week MA | $42.5 | 29% below |
BF-B has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
BF-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $67.9 | $78.0 | +15% |
| 2021 | $78.0 | $71.7 | -8.1% |
| 2022 | $71.7 | $66.4 | -7.5% |
| 2023 | $66.4 | $57.1 | -14% |
| 2024 | $57.1 | $38.8 | -32% |
| 2025 | $38.8 | $26.2 | -33% |
| 2026 YTD | $26.2 | $30.0 | +15% |
BF-B has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.